Skip to content

The differences of suppression of Tregs to NK action in different courses of chronic hepatitis

The differences of suppression of Tregs to NK action in different courses of chronic hepatitis

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CPC-15006299
Enrollment
Unknown
Registered
2014-08-15
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver diseases

Interventions

Chronic HBV infected :Nil
cirrhosis with HBV:Nil
Chronic HCV infected:Nil
cirrhosis with HCV:Nil

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-70 years old, male or female; 2. HBV or HVC infectived chronic patients,liver cirrhosis with HBV or HCV; 3. The diagnosis of liver cirrhosis was suppoted at least either B ultrasound or CT results bescides liver function and routine blood test.

Exclusion criteria

Exclusion criteria: 1. Hepatic cancer and other immune system diseases and viral diseases; 2. Combined with other causes (including autoimmune, alcohol or drugs) to chronic liver disease; 3. In addition to the liver injury, accompanied with other serious activities of physical and mental diseases, including not controlled primary kidney, heart, lung, blood vessel, nerve, digestive and metabolic diseases; 4. Received the study drug or immune therapy within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Regulatory T cell;Natural killer cell;

Countries

China

Contacts

Public ContactXiaohui Zhang
zhangxiaohui_111@163.com+86 010-63291007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026